Logo Image
Opinion|Videos|September 30, 2024

Overcoming Barriers to Prescribing First-Line Medications for CRM Conditions

Key Takeaways

  • Enhancing physician awareness and understanding of SGLT2 inhibitors and GLP1-receptor agonists can increase prescription rates.
  • Streamlining insurance approval processes and advocating for policy changes are crucial for improving medication coverage.
SHOW MORE

The expert panel analyzes strategies for overcoming barriers to prescribing first-line medications for cardiometabolic conditions.

Episodes in this series

Video content above is prompted by the following:

  • Despite being approved for first-line treatment, medications such as SGLT2 inhibitors and GLP1-receptor agonists are not frequently prescribed to qualified patients. What has been effective in your practice to get these first line medications covered in the patient population who needs it the most?

This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.

Related Content